<p>紐約，2026 年 4 月 23 日（全球新聞稿）——國家醫療物業公司（“NHP”）今天宣佈以每股 12.00 美元的價格完成了 3850 萬股 A 類普通股的公開發行。NHP 的 A 類普通股於 2026 年 4 月 22 日在納斯達克全球市場開始交易，交易代碼為 “NHP”。NHP 已向承銷商授予 30 天的選擇權，以購買最多 577.5 萬股 A 類普通股以覆蓋超額配售（如有）。</p>
<p>NHP 打算將此次發行所獲得的淨收益用於償還約 1.86 億美元的循環信貸設施下的未償債務，資助潛在的未來物業收購以及其他一般企業用途。</p>
<p>富國證券、摩根士丹利和 BMO 資本市場擔任此次發行的主要賬簿管理人。高盛集團、RBC 資本市場、貝爾德、Capital One 證券、第五第三證券、亨廷頓資本市場和 KeyBanc 資本市場擔任此次發行的賬簿管理人。法國農業信貸銀行和 Synovus 擔任此次發行的共同管理人。</p>
<p>此次發行僅通過招股説明書進行。有關此次發行的最終招股説明書的副本可從以下地址獲取：富國證券，LLC，明尼阿波利斯南七街 90 號，五樓，明尼蘇達州 55402，電話（800）645-3751（選項#5），或通過電子郵件聯繫 WFScustomerservice@wellsfargo.com；摩根士丹利，LLC，收件人：招股説明書部門，紐約市瓦里克街 180 號，二樓，郵政編碼 10014；或 BMO 資本市場公司，收件人：股權承銷部門，紐約市西 42 街 151 號，三十二樓，郵政編碼 10036，或通過電子郵件聯繫 bmoprospectus@bmo.com。</p>
<p>與此次發行相關的註冊聲明已獲得證券交易委員會（“SEC”）的有效聲明。本新聞稿不構成出售證券的要約或購買證券的要約邀請，也不應在任何州或其他司法管轄區進行證券的出售，除非在任何此類州或司法管轄區的證券法下進行註冊或資格認證之前，此類要約、邀請或出售是非法的。</p>
<p><strong>關於國家醫療物業公司</strong></p>
<p>國家醫療物業公司是一家公開註冊的房地產投資信託，專注於收購多元化的醫療房地產投資組合，重點是位於美國的老年住房和門診醫療設施。</p>
<p><strong>前瞻性聲明</strong></p>
<p>本新聞稿包含根據 1995 年《私人證券訴訟改革法》定義的 “前瞻性” 聲明。這些前瞻性聲明涉及並基於以下內容：NHP 對發行收益的使用；以及實現任何潛在優勢、利益及此次發行所創造的影響和機會。當 NHP 使用 “可能”、“將”、“打算”、“應該”、“相信”、“期望”、“預期”、“項目”、“估計” 或類似表達時，它是在做出前瞻性聲明。前瞻性聲明並不保證未來的表現，並涉及風險和不確定性。NHP 預期的結果可能無法實現，實際結果可能與預期有重大差異。這可能是由於各種因素，包括但不限於在與此次發行相關的註冊聲明中標題為 “風險因素” 的部分以及與 SEC 的所有其他文件中描述的風險和不確定性。最後，NHP 不承擔更新或修訂任何前瞻性聲明的義務，也不更新實際結果可能與任何前瞻性聲明中預測的結果不同的原因。</p>
<p><strong>聯繫方式</strong></p>
<p><strong>投資者和媒體：</strong></p>
<p>電子郵件：ir@nhpreit.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZNU5Ua3hOQ00zTlRVeU5URTFJekl5T1RjM01UQT0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZNU5Ua3hOQ00zTlRVeU5URTFJekl5T1RjM01UQT0"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MzA2OWUzM2UtMTUyZi00NjQ0LTg0NWYtMWFhYTZkMGNhMzk5LTEzMDkyNjAtMjAyNi0wNC0yMy1lbg==/tiny/National-Healthcare-Properties.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MzA2OWUzM2UtMTUyZi00NjQ0LTg0NWYtMWFhYTZkMGNhMzk5LTEzMDkyNjAtMjAyNi0wNC0yMy1lbg==/tiny/National-Healthcare-Properties.png"/></p>

NHPAP

NHPBP

<p>國家醫療物業公司（National Healthcare Properties, Inc.，簡稱 NHP）已完成其 3850 萬股 A 類普通股的公開發行，發行價格為每股 12.00 美元，交易將在納斯達克以 “NHP” 符號開始。該公司計劃將所得款項用於償還 1.86 億美元的債務、資助未來的收購以及一般企業用途。此次發行包括承銷商在 30 天內購買額外 577.5 萬股的選擇權。富國證券、摩根士丹利和 BMO 資本市場主導了此次發行，該發行已向美國證券交易委員會（SEC）註冊</p>

<p>NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (“NHP”) today announced the closing of its public offering of 38,500,000 shares of its Class A common stock at $12.00 per share. Shares of NHP’s Class A common stock began trading on The Nasdaq Global Market on April 22, 2026 under the symbol “NHP.” NHP has granted the underwriters a 30-day option to purchase up to an additional 5,775,000 shares of its Class A common stock to cover overallotments, if any.</p>
<div class="lb-trans"><p>紐約，2026 年 4 月 23 日（全球新聞稿）——國家醫療物業公司（“NHP”）今天宣佈以每股 12.00 美元的價格完成了 3850 萬股 A 類普通股的公開發行。NHP 的 A 類普通股於 2026 年 4 月 22 日在納斯達克全球市場開始交易，交易代碼為 “NHP”。NHP 已向承銷商授予 30 天的選擇權，以購買最多 577.5 萬股 A 類普通股以覆蓋超額配售（如有）。</p>
</div><p>NHP intends to use the net proceeds received from the offering to repay approximately $186.0 million of outstanding indebtedness under its revolving credit facility, to fund potential future property acquisitions and for other general corporate purposes.</p>
<div class="lb-trans"><p>NHP 打算將此次發行所獲得的淨收益用於償還約 1.86 億美元的循環信貸設施下的未償債務，資助潛在的未來物業收購以及其他一般企業用途。</p>
</div><p>Wells Fargo Securities, Morgan Stanley and BMO Capital Markets acted as lead book-running managers for the offering. Goldman Sachs &amp; Co. LLC, RBC Capital Markets, Baird, Capital One Securities, Fifth Third Securities, Huntington Capital Markets and KeyBanc Capital Markets acted as bookrunners for the offering. Credit Agricole CIB and Synovus acted as co-managers for the offering.</p>
<div class="lb-trans"><p>富國證券、摩根士丹利和 BMO 資本市場擔任此次發行的主要賬簿管理人。高盛集團、RBC 資本市場、貝爾德、Capital One 證券、第五第三證券、亨廷頓資本市場和 KeyBanc 資本市場擔任此次發行的賬簿管理人。法國農業信貸銀行和 Synovus 擔任此次發行的共同管理人。</p>
</div><p>The offering was made only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained from: Wells Fargo Securities, LLC, 90 South 7th Street, 5th Floor, Minneapolis, Minnesota 55402, by telephone at (800) 645-3751 (option #5), or by email at WFScustomerservice@wellsfargo.com; Morgan Stanley &amp; Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014; or BMO Capital Markets Corp., Attn: Equity Syndicate Department, 151 West 42nd Street, 32nd Floor, New York, New York 10036, or by email at bmoprospectus@bmo.com.</p>
<div class="lb-trans"><p>此次發行僅通過招股説明書進行。有關此次發行的最終招股説明書的副本可從以下地址獲取：富國證券，LLC，明尼阿波利斯南七街 90 號，五樓，明尼蘇達州 55402，電話（800）645-3751（選項#5），或通過電子郵件聯繫 WFScustomerservice@wellsfargo.com；摩根士丹利，LLC，收件人：招股説明書部門，紐約市瓦里克街 180 號，二樓，郵政編碼 10014；或 BMO 資本市場公司，收件人：股權承銷部門，紐約市西 42 街 151 號，三十二樓，郵政編碼 10036，或通過電子郵件聯繫 bmoprospectus@bmo.com。</p>
</div><p>A registration statement relating to the offering has been declared effective by the Securities and Exchange Commission (the “SEC”). This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p>
<div class="lb-trans"><p>與此次發行相關的註冊聲明已獲得證券交易委員會（“SEC”）的有效聲明。本新聞稿不構成出售證券的要約或購買證券的要約邀請，也不應在任何州或其他司法管轄區進行證券的出售，除非在任何此類州或司法管轄區的證券法下進行註冊或資格認證之前，此類要約、邀請或出售是非法的。</p>
</div><p><strong>About National Healthcare Properties, Inc.</strong></p>
<div class="lb-trans"><p><strong>關於國家醫療物業公司</strong></p>
</div><p>National Healthcare Properties, Inc. is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on senior housing and outpatient medical facilities located in the United States.</p>
<div class="lb-trans"><p>國家醫療物業公司是一家公開註冊的房地產投資信託，專注於收購多元化的醫療房地產投資組合，重點是位於美國的老年住房和門診醫療設施。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性聲明</strong></p>
</div><p>This press release contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements concern and are based upon, among other things: NHP’s use of proceeds from the offering; and the realization of any potential advantages, benefits and the impact of, and opportunities created by, the offering. When NHP uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. NHP’s expected results may not be achieved, and actual results may differ materially from expectations. This may be a result of various factors, including, but not limited, the risks and uncertainties described in the section titled “Risk Factors” in the registration statement relating to the offering and all other filings with the SEC. Finally, NHP assumes no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.</p>
<div class="lb-trans"><p>本新聞稿包含根據 1995 年《私人證券訴訟改革法》定義的 “前瞻性” 聲明。這些前瞻性聲明涉及並基於以下內容：NHP 對發行收益的使用；以及實現任何潛在優勢、利益及此次發行所創造的影響和機會。當 NHP 使用 “可能”、“將”、“打算”、“應該”、“相信”、“期望”、“預期”、“項目”、“估計” 或類似表達時，它是在做出前瞻性聲明。前瞻性聲明並不保證未來的表現，並涉及風險和不確定性。NHP 預期的結果可能無法實現，實際結果可能與預期有重大差異。這可能是由於各種因素，包括但不限於在與此次發行相關的註冊聲明中標題為 “風險因素” 的部分以及與 SEC 的所有其他文件中描述的風險和不確定性。最後，NHP 不承擔更新或修訂任何前瞻性聲明的義務，也不更新實際結果可能與任何前瞻性聲明中預測的結果不同的原因。</p>
</div><p><strong>Contacts</strong></p>
<div class="lb-trans"><p><strong>聯繫方式</strong></p>
</div><p><strong>Investors and Media:</strong></p>
<div class="lb-trans"><p><strong>投資者和媒體：</strong></p>
</div><p>Email: ir@nhpreit.com</p>
<div class="lb-trans"><p>電子郵件：ir@nhpreit.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZNU5Ua3hOQ00zTlRVeU5URTFJekl5T1RjM01UQT0" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTY5NTkxNCM3NTUyNTE1IzIyOTc3MTA="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MzA2OWUzM2UtMTUyZi00NjQ0LTg0NWYtMWFhYTZkMGNhMzk5LTEzMDkyNjAtMjAyNi0wNC0yMy1lbg==/tiny/National-Healthcare-Properties.png" alt="" original-src="https://ml.globenewswire.com/media/MzA2OWUzM2UtMTUyZi00NjQ0LTg0NWYtMWFhYTZkMGNhMzk5LTEzMDkyNjAtMjAyNi0wNC0yMy1lbg==/tiny/National-Healthcare-Properties.png"/></p>

National Healthcare Properties Announces Closing of Public Offering | NHPAP Stock News

StockTitan

National Healthcare Pref Share HTIA 7.375

National Healthcare Pref Share HTIBP 7.125 Perp 10/06/26 B

Healthcare Trust Pref Share HTIA 7.375

富國銀行

摩根士丹利

蒙特利爾銀行

高盛

加拿大皇家銀行

第一資本金融

五三銀行

Huntington Bancshares

科凱國際

Synovus Financial

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

GS Hldg R

CAPITAL ONE FINANCIAL CORP DEP SHS REP 1/40TH NCUM PFD SER N

CAPITAL ONE FINANCIAL CORP 4.8% DP SH RP 1/40TH NON CUM PERP PFD J

CAPITAL ONE FINANCIAL CORP DEP SHS REP 1/40TH NON CUM PERP PFD  I

五三銀行-存託優先股Series K

Fifth Third Bancorp Pref Shares FITBM 6.875 Perp 10/01/30

五三銀行-Series A

KEYCORP DEP SHS REP 1/40TH NON CUM PER PFD SER G

KEYCORP DEP SHS REPSTG 1/40TH INT PERP NON CUM H

KEYCORP DEP SHS REP 1/40TH PERP PFD SER F USD25

KEYCORP DEP SHS REP 1/40TH NON CUM PFD SER E

SYNOVUS FINANCIAL CORP 5.875% FXD FLTG NON CUM PER PFD STK SR E

SYNOVUS FINANCIAL CORP NON CUM PER PFD FXD TO FLTG SER D USD 25

國家醫療地產宣佈完成公開發行 | NHPAP 股票新聞